HLS Therapeutics Standard Deviation
| HLS Stock | | | CAD 4.40 0.11 2.56% |
Observed values used to calculate the Standard Deviation technical indicator for HLS Therapeutics. Indicator inputs depend on available historical price observations.
HLS Therapeutics has current Standard Deviation of 1.09. The Standard Deviation is a measure of how spread out the prices or returns of an asset are on average. It is the most widely used risk indicator in the field of investing and finance. Standard Deviation is commonly used to measure confidence in statistical conclusions regarding certain equity instruments or portfolios of equities.
Standard Deviation | = | SQRT(V) |
| = | 1.09 | |
Standard Deviation Peers Comparison
Standard Deviation Relative To Other Indicators
HLS Therapeutics is rated
below average in standard deviation compared to key competitors. It is currently under evaluation in maximum drawdown compared to key competitors producing
5.16 in Maximum Drawdown for each unit of Standard Deviation. The spread between Maximum Drawdown and Standard Deviation for HLS Therapeutics sits at
5.16 Standard deviation is applied to the annual rate of return of an investment to measure the investment's volatility. Standard deviation is also known as historical volatility and is used by investors as a gauge for the amount of expected market volatility. A large standard deviation usually indicates that the data points are far from the mean and a small standard deviation indicates that they are clustered closely around the mean.
Compare HLS Therapeutics to Peers
Other Technical Indicators